skip to main content
Show Results with:

Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?

Diem, Stefan et al.

Journal of immunotherapy: official journal of the Society for Biological Therapy. Volume 39:Issue 9 (2016, November/December) -- Lippincott Williams & Wilkins

Online access

Notes here allow you and other users to comment and make notes on items, viewable by the whole community.
NB: Please use the Report Catalogue Error form to advise us of catalogue inaccuracies.

Log in to add a note

Tags allow you and others to define and search on related groups of items.

Log in to add / remove tags

Searching Remote Databases, Please Wait